SAN FRANCISCO, April 04, 2023 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical…
Collaboration drives digital transformation with Microsoft Azure, build better experiences for customers and employees DRAPER, Utah, April 04, 2023 (GLOBE…
MONT-SAINT-GUIBERT, Belgium, April 04, 2023 (GLOBE NEWSWIRE) — Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company focused…